Skip to main content
ConductScienceScienceDex

Alexander B Sigalov

NIH Rank #7049
Unclaimed recordClaim profile
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10750414Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2025 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Biochemistry

NIH Funding · FY2025

Linked Award Amount
$1.9M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#7,049
By linked amount among FY2025 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Alexander B Sigalov. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Alexander B Sigalov as a PI. Multi-PI records show the full award amount for context.

  • 4R44EY034015-02R44
    First-in-class TREM-1 inhibitors for neovascular retinal diseases
    Signablok, Inc.
    $830.5K
    award amount
  • 1R61HL175690-01A1R61
    Concurrent targeting of inflammation and the inhibition of the fibrinolytic system to increase the efficacy of empyema treatment
    University of Texas Hlth Ctr at Tyler
    $499.6K
    award amount
  • 1R43HL174220-01A1R43
    TREM-1 therapy for the treatment of empyema
    Signablok, Inc.
    $458K
    award amount
  • 1R21AI193495-01R21
    Novel medical countermeasure to mitigate potentially lethal acute radiation syndrome
    Signablok, Inc.
    $155.9K
    award amount

Award organizations

Organizations that administered FY2025 awards listing Alexander B Sigalov as a PI.

Signablok, Inc.
MA
$1.4M
3 grants
University of Texas Hlth Ctr at Tyler
TX
$499.6K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2025
    First NIH Award
    Signablok, Inc.
  2. 2025
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    Entered Top 50% Nationally
    Ranked #7049
  5. 2026
    $2M Cumulative Funding
  6. 2026
    Multi-Institutional Research
    Awards at 2 institutions

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Alexander B Sigalov.

Andrey Komissarov
University of Texas Hlth Ctr at Tyler
1
shared award

Explore further

Find collaborators for Alexander B Sigalov

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →